Immature truncated O-glycophenotype of cancer directly induces oncogenic features

Prakash Radhakrishnan, Sally Dabelsteen, Frey Brus Madsen, Chiara Francavilla, Katharina L. Kopp, Catharina Steentoft, Sergey Y. Vakhrushev, Jesper V. Olsen, Lars Hansen, Eric P. Bennett, Anders Woetmann, Guangliang Yin, Longyun Chen, Haiyan Song, Mads Bak, Ryan A. Hlady, Staci L. Peters, Rene Opavsky, Christenze Thode, Klaus QvortrupKatrine T B G Schjoldager, Henrik Clausen, Michael A Hollingsworth, Hans H. Wandall

Research output: Contribution to journalArticle

113 Citations (Scopus)

Abstract

Aberrant expression of immature truncated O-glycans is a characteristic feature observed on virtually all epithelial cancer cells, and a very high frequency is observed in early epithelial premalignant lesions that precede the development of adenocarcinomas. Expression of the truncated O-glycan structures Tn and sialyl-Tn is strongly associated with poor prognosis and overall low survival. The genetic and biosynthetic mechanisms leading to accumulation of truncated O-glycans are not fully understood and include mutation or dysregulation of glycosyltransferases involved in elongation of O-glycans, as well as relocation of glycosyltransferases controlling initiation of O-glycosylation from Golgi to endoplasmic reticulum. Truncated O-glycans have been proposed to play functional roles for cancer-cell invasiveness, but our understanding of the biological functions of aberrant glycosylation in cancer is still highly limited. Here, we used exome sequencing of most glycosyltransferases in a large series of primary and metastatic pancreatic cancers to rule out somatic mutations as a cause of expression of truncated O-glycans. Instead, we found hypermethylation of core 1 β3-Gal-T-specific molecular chaperone, a key chaperone for O-glycan elongation, as the most prevalent cause. We next used gene editing to produce isogenic cell systems with and without homogenous truncated O-glycans that enabled, to our knowledge, the first polyomic and side-by-side evaluation of the cancer O-glycophenotype in an organotypic tissue model and in xenografts. The results strongly suggest that truncation of O-glycans directly induces oncogenic features of cell growth and invasion. The study provides support for targeting cancer-specific truncated O-glycans with immunotherapeutic measures.

Original languageEnglish (US)
Pages (from-to)E4066-E4075
JournalProceedings of the National Academy of Sciences of the United States of America
Volume111
Issue number39
DOIs
StatePublished - Sep 30 2014

Fingerprint

Polysaccharides
Neoplasms
Glycosyltransferases
Glycosylation
Exome
Mutation
Molecular Chaperones
Pancreatic Neoplasms
Heterografts
Endoplasmic Reticulum
Adenocarcinoma
Epithelial Cells
Growth

Keywords

  • Epigenetics
  • Glycans
  • Keratinocyte
  • Pancreas
  • Skin

ASJC Scopus subject areas

  • General

Cite this

Immature truncated O-glycophenotype of cancer directly induces oncogenic features. / Radhakrishnan, Prakash; Dabelsteen, Sally; Madsen, Frey Brus; Francavilla, Chiara; Kopp, Katharina L.; Steentoft, Catharina; Vakhrushev, Sergey Y.; Olsen, Jesper V.; Hansen, Lars; Bennett, Eric P.; Woetmann, Anders; Yin, Guangliang; Chen, Longyun; Song, Haiyan; Bak, Mads; Hlady, Ryan A.; Peters, Staci L.; Opavsky, Rene; Thode, Christenze; Qvortrup, Klaus; Schjoldager, Katrine T B G; Clausen, Henrik; Hollingsworth, Michael A; Wandall, Hans H.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 111, No. 39, 30.09.2014, p. E4066-E4075.

Research output: Contribution to journalArticle

Radhakrishnan, P, Dabelsteen, S, Madsen, FB, Francavilla, C, Kopp, KL, Steentoft, C, Vakhrushev, SY, Olsen, JV, Hansen, L, Bennett, EP, Woetmann, A, Yin, G, Chen, L, Song, H, Bak, M, Hlady, RA, Peters, SL, Opavsky, R, Thode, C, Qvortrup, K, Schjoldager, KTBG, Clausen, H, Hollingsworth, MA & Wandall, HH 2014, 'Immature truncated O-glycophenotype of cancer directly induces oncogenic features', Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 39, pp. E4066-E4075. https://doi.org/10.1073/pnas.1406619111
Radhakrishnan, Prakash ; Dabelsteen, Sally ; Madsen, Frey Brus ; Francavilla, Chiara ; Kopp, Katharina L. ; Steentoft, Catharina ; Vakhrushev, Sergey Y. ; Olsen, Jesper V. ; Hansen, Lars ; Bennett, Eric P. ; Woetmann, Anders ; Yin, Guangliang ; Chen, Longyun ; Song, Haiyan ; Bak, Mads ; Hlady, Ryan A. ; Peters, Staci L. ; Opavsky, Rene ; Thode, Christenze ; Qvortrup, Klaus ; Schjoldager, Katrine T B G ; Clausen, Henrik ; Hollingsworth, Michael A ; Wandall, Hans H. / Immature truncated O-glycophenotype of cancer directly induces oncogenic features. In: Proceedings of the National Academy of Sciences of the United States of America. 2014 ; Vol. 111, No. 39. pp. E4066-E4075.
@article{36afbb92e9bf4dfebcf9ae6264745e67,
title = "Immature truncated O-glycophenotype of cancer directly induces oncogenic features",
abstract = "Aberrant expression of immature truncated O-glycans is a characteristic feature observed on virtually all epithelial cancer cells, and a very high frequency is observed in early epithelial premalignant lesions that precede the development of adenocarcinomas. Expression of the truncated O-glycan structures Tn and sialyl-Tn is strongly associated with poor prognosis and overall low survival. The genetic and biosynthetic mechanisms leading to accumulation of truncated O-glycans are not fully understood and include mutation or dysregulation of glycosyltransferases involved in elongation of O-glycans, as well as relocation of glycosyltransferases controlling initiation of O-glycosylation from Golgi to endoplasmic reticulum. Truncated O-glycans have been proposed to play functional roles for cancer-cell invasiveness, but our understanding of the biological functions of aberrant glycosylation in cancer is still highly limited. Here, we used exome sequencing of most glycosyltransferases in a large series of primary and metastatic pancreatic cancers to rule out somatic mutations as a cause of expression of truncated O-glycans. Instead, we found hypermethylation of core 1 β3-Gal-T-specific molecular chaperone, a key chaperone for O-glycan elongation, as the most prevalent cause. We next used gene editing to produce isogenic cell systems with and without homogenous truncated O-glycans that enabled, to our knowledge, the first polyomic and side-by-side evaluation of the cancer O-glycophenotype in an organotypic tissue model and in xenografts. The results strongly suggest that truncation of O-glycans directly induces oncogenic features of cell growth and invasion. The study provides support for targeting cancer-specific truncated O-glycans with immunotherapeutic measures.",
keywords = "Epigenetics, Glycans, Keratinocyte, Pancreas, Skin",
author = "Prakash Radhakrishnan and Sally Dabelsteen and Madsen, {Frey Brus} and Chiara Francavilla and Kopp, {Katharina L.} and Catharina Steentoft and Vakhrushev, {Sergey Y.} and Olsen, {Jesper V.} and Lars Hansen and Bennett, {Eric P.} and Anders Woetmann and Guangliang Yin and Longyun Chen and Haiyan Song and Mads Bak and Hlady, {Ryan A.} and Peters, {Staci L.} and Rene Opavsky and Christenze Thode and Klaus Qvortrup and Schjoldager, {Katrine T B G} and Henrik Clausen and Hollingsworth, {Michael A} and Wandall, {Hans H.}",
year = "2014",
month = "9",
day = "30",
doi = "10.1073/pnas.1406619111",
language = "English (US)",
volume = "111",
pages = "E4066--E4075",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "39",

}

TY - JOUR

T1 - Immature truncated O-glycophenotype of cancer directly induces oncogenic features

AU - Radhakrishnan, Prakash

AU - Dabelsteen, Sally

AU - Madsen, Frey Brus

AU - Francavilla, Chiara

AU - Kopp, Katharina L.

AU - Steentoft, Catharina

AU - Vakhrushev, Sergey Y.

AU - Olsen, Jesper V.

AU - Hansen, Lars

AU - Bennett, Eric P.

AU - Woetmann, Anders

AU - Yin, Guangliang

AU - Chen, Longyun

AU - Song, Haiyan

AU - Bak, Mads

AU - Hlady, Ryan A.

AU - Peters, Staci L.

AU - Opavsky, Rene

AU - Thode, Christenze

AU - Qvortrup, Klaus

AU - Schjoldager, Katrine T B G

AU - Clausen, Henrik

AU - Hollingsworth, Michael A

AU - Wandall, Hans H.

PY - 2014/9/30

Y1 - 2014/9/30

N2 - Aberrant expression of immature truncated O-glycans is a characteristic feature observed on virtually all epithelial cancer cells, and a very high frequency is observed in early epithelial premalignant lesions that precede the development of adenocarcinomas. Expression of the truncated O-glycan structures Tn and sialyl-Tn is strongly associated with poor prognosis and overall low survival. The genetic and biosynthetic mechanisms leading to accumulation of truncated O-glycans are not fully understood and include mutation or dysregulation of glycosyltransferases involved in elongation of O-glycans, as well as relocation of glycosyltransferases controlling initiation of O-glycosylation from Golgi to endoplasmic reticulum. Truncated O-glycans have been proposed to play functional roles for cancer-cell invasiveness, but our understanding of the biological functions of aberrant glycosylation in cancer is still highly limited. Here, we used exome sequencing of most glycosyltransferases in a large series of primary and metastatic pancreatic cancers to rule out somatic mutations as a cause of expression of truncated O-glycans. Instead, we found hypermethylation of core 1 β3-Gal-T-specific molecular chaperone, a key chaperone for O-glycan elongation, as the most prevalent cause. We next used gene editing to produce isogenic cell systems with and without homogenous truncated O-glycans that enabled, to our knowledge, the first polyomic and side-by-side evaluation of the cancer O-glycophenotype in an organotypic tissue model and in xenografts. The results strongly suggest that truncation of O-glycans directly induces oncogenic features of cell growth and invasion. The study provides support for targeting cancer-specific truncated O-glycans with immunotherapeutic measures.

AB - Aberrant expression of immature truncated O-glycans is a characteristic feature observed on virtually all epithelial cancer cells, and a very high frequency is observed in early epithelial premalignant lesions that precede the development of adenocarcinomas. Expression of the truncated O-glycan structures Tn and sialyl-Tn is strongly associated with poor prognosis and overall low survival. The genetic and biosynthetic mechanisms leading to accumulation of truncated O-glycans are not fully understood and include mutation or dysregulation of glycosyltransferases involved in elongation of O-glycans, as well as relocation of glycosyltransferases controlling initiation of O-glycosylation from Golgi to endoplasmic reticulum. Truncated O-glycans have been proposed to play functional roles for cancer-cell invasiveness, but our understanding of the biological functions of aberrant glycosylation in cancer is still highly limited. Here, we used exome sequencing of most glycosyltransferases in a large series of primary and metastatic pancreatic cancers to rule out somatic mutations as a cause of expression of truncated O-glycans. Instead, we found hypermethylation of core 1 β3-Gal-T-specific molecular chaperone, a key chaperone for O-glycan elongation, as the most prevalent cause. We next used gene editing to produce isogenic cell systems with and without homogenous truncated O-glycans that enabled, to our knowledge, the first polyomic and side-by-side evaluation of the cancer O-glycophenotype in an organotypic tissue model and in xenografts. The results strongly suggest that truncation of O-glycans directly induces oncogenic features of cell growth and invasion. The study provides support for targeting cancer-specific truncated O-glycans with immunotherapeutic measures.

KW - Epigenetics

KW - Glycans

KW - Keratinocyte

KW - Pancreas

KW - Skin

UR - http://www.scopus.com/inward/record.url?scp=84907572385&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907572385&partnerID=8YFLogxK

U2 - 10.1073/pnas.1406619111

DO - 10.1073/pnas.1406619111

M3 - Article

C2 - 25118277

AN - SCOPUS:84907572385

VL - 111

SP - E4066-E4075

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 39

ER -